A possible breakthrough by scientists in the treatment of HIV-1 infection with the finding of an effective way to eradicate an obstinate form of the virus that’s unresponsive to existing therapies. The research describes a vaccination strategy that may be essential for successful eradication efforts and should therefore be considered for future clinical trials.
Current antiretroviral therapies suppress the ability of HIV-1 to copy itself, but they cannot completely eliminate the virus. Under these treatment conditions, HIV-1 enters a silent, or "latent", state that rapidly becomes active again as soon therapy is stopped.
"Because of the stability of latent HIV-1 inside of infected T cells, lifelong antiretroviral therapy is required, raising concerns about adverse affects over decades of therapy, the evolution of resistance, and the financial burden of treatment," explained senior study author, Dr. Robert F. Siliciano, from the Johns Hopkins University School of Medicine.
"Therefore, there is an urgent need for strategies to eradicate HIV-1 from infected individuals," he noted
Previous research has suggested that reactivation of the latent HIV-1 is an important first step for complete elimination of the virus, but it is not clear whether the activated virus or the host immune response will then lead to elimination of the infected cells.
In the current study, Dr. Siliciano and colleagues observed that infected T cells survived after the latent virus was reactivated. However, when the immune response of the host T cells was heightened before the virus was reactivated, the infected cells were efficiently eliminated.
Advertisement
"Therefore, an appropriately timed vaccination that boosts the response of the immune system to HIV-1 may be critical for therapies that move beyond suppression of HIV-1 to true elimination," he added.
Advertisement
Source-ANI